Pharmaceutical Market Europe • May 2026 • 27
MARKETING & COMMS
May Highlights
28-29
MAKING HEADWAY TOWARDS GREATER PATIENT ACCESS THROUGH FAVOURABLE TRADE WINDS AND MARKET DEALS
Regulatory changes and tariffs have created a positive climate for investment, innovation and, critically, patient access to therapies
34-35
HEALTHCARE COMMS
Exploring important topics affecting the healthcare comms industry today, from human-centricity in trial design to how GenAI can strengthen engagement with HCPs
Changes at Cue Biopharma, AbbVie and CNX Therapeutics
Changes at Ovid Health, Langland, Envision and Zeno